• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰的食管癌:发病率和死亡率上升,但生存率提高。

Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival.

作者信息

Crane Lucia M A, Schaapveld Michael, Visser Otto, Louwman Marieke W J, Plukker John T M, van Dam Gooitzen M

机构信息

Department of Surgery, Division of Surgical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands.

出版信息

Eur J Cancer. 2007 Jun;43(9):1445-51. doi: 10.1016/j.ejca.2007.03.024. Epub 2007 May 23.

DOI:10.1016/j.ejca.2007.03.024
PMID:17512189
Abstract

AIM

Oesophageal cancer is highly lethal with a 5-year relative survival of 10-15%. An increasing incidence has been reported for several parts of the Western world. We studied time trends in incidence, mortality and survival for oesophageal cancer in the Netherlands during 1989-2003.

METHODS

Data on incidence and survival were obtained from the Netherlands Cancer Registry and mortality data from Statistics Netherlands.

RESULTS

The age standardised incidence increased by 3.4% (p<0.001) and 1.9% (p=0.003) per year for males and females, respectively. This increase was almost exclusively caused by oesophageal adenocarcinomas. Age standardised mortality increased 2.5% (p<0.001) per year among males and 1.7% (p=0.002) per year among females. Relative survival improved significantly from 8.1% in 1989-1993 to 12.6% in 1999-2003 (p<0.001). Adjusted for age, stage, tumour location and surgery, the excess risk of death decreased by 22%.

CONCLUSION

Oesophageal carcinoma incidence is rising in the Netherlands. Mortality increased at a slightly lower pace due to improving survival.

摘要

目的

食管癌具有高度致死性,5年相对生存率为10% - 15%。据报道,在西方世界的几个地区,其发病率呈上升趋势。我们研究了1989年至2003年荷兰食管癌发病率、死亡率和生存率的时间趋势。

方法

发病率和生存率数据来自荷兰癌症登记处,死亡率数据来自荷兰统计局。

结果

男性和女性的年龄标准化发病率分别每年增加3.4%(p<0.001)和1.9%(p = 0.003)。这种增加几乎完全是由食管腺癌引起的。男性年龄标准化死亡率每年增加2.5%(p<0.001),女性每年增加1.7%(p = 0.002)。相对生存率从1989 - 1993年的8.1%显著提高到1999 - 2003年的12.6%(p<0.001)。经年龄、分期、肿瘤位置和手术调整后,死亡超额风险降低了22%。

结论

荷兰食管癌发病率正在上升。由于生存率提高,死亡率上升速度略低。

相似文献

1
Oesophageal cancer in The Netherlands: increasing incidence and mortality but improving survival.荷兰的食管癌:发病率和死亡率上升,但生存率提高。
Eur J Cancer. 2007 Jun;43(9):1445-51. doi: 10.1016/j.ejca.2007.03.024. Epub 2007 May 23.
2
[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands].[1989年至2003年荷兰癌症发病率和死亡率趋势]
Ned Tijdschr Geneeskd. 2006 Nov 11;150(45):2490-6.
3
[Lung cancer in the Netherlands in the period 1989-1997: the epidemic is not over yet].[1989 - 1997年荷兰的肺癌情况:流行尚未结束]
Ned Tijdschr Geneeskd. 2001 Mar 3;145(9):419-23.
4
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.荷兰食管癌发病率和生存率上升,但贲门胃癌无此变化。
Eur J Cancer. 2012 Jul;48(11):1624-32. doi: 10.1016/j.ejca.2012.01.009. Epub 2012 Feb 6.
5
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands.1990 年至 2007 年期间胃腺癌发病率、治疗和生存趋势:荷兰基于人群的研究。
Eur J Cancer. 2010 Apr;46(6):1101-10. doi: 10.1016/j.ejca.2010.02.013. Epub 2010 Mar 8.
6
Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival.荷兰南部 1975-2007 年结直肠癌发病趋势:直肠癌生存率与结肠癌生存率比较。
Acta Oncol. 2010 Aug;49(6):784-96. doi: 10.3109/02841861003733713.
7
Changing trends in incidence and mortality of thyroid cancer in Scotland.苏格兰甲状腺癌发病率和死亡率的变化趋势
Clin Endocrinol (Oxf). 2005 Feb;62(2):156-62. doi: 10.1111/j.1365-2265.2004.02187.x.
8
[Trends in cancer incidence and cancer mortality in Netherlands: good and bad news].[荷兰癌症发病率和癌症死亡率趋势:好消息与坏消息]
Ned Tijdschr Geneeskd. 1999 Jul 17;143(29):1502-6.
9
Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.荷兰的卵巢癌发病率(1989 - 1991年)及死亡率(1954 - 1993年)。
Obstet Gynecol. 1996 Sep;88(3):387-93. doi: 10.1016/0029-7844(96)00198-6.
10
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.1975 - 2004年确诊的乳腺癌患者发病率和预后的上升趋势:荷兰东南部一项基于人群的长期研究
Cancer Causes Control. 2008 Feb;19(1):97-106. doi: 10.1007/s10552-007-9075-8. Epub 2007 Nov 24.

引用本文的文献

1
Definitive chemoradiotherapy in elderly patients with esophageal cancer: Safety and outcome.老年食管癌患者的根治性放化疗:安全性与疗效
Precis Radiat Oncol. 2023 Mar 25;7(1):51-58. doi: 10.1002/pro6.1190. eCollection 2023 Mar.
2
Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3).全球食管癌生存率的亚部位、形态和性别趋势分析:60 个国家 696974 名成年人 2000-2014 年的诊断情况(CONCORD-3)。
Cancer Commun (Lond). 2023 Sep;43(9):963-980. doi: 10.1002/cac2.12457. Epub 2023 Jul 24.
3
Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett's esophagus diagnosed in community hospitals.
社区医院诊断的巴雷特食管伴固有性低级别上皮内瘤变的专家中心内镜评估的影响。
Endoscopy. 2022 Oct;54(10):936-944. doi: 10.1055/a-1754-7309. Epub 2022 Jan 28.
4
Definitive chemoradiation in locally advanced inoperable esophageal cancer patients - Retrospective analysis of different chemotherapy regimens in a tertiary cancer centre.局部晚期不可切除食管癌患者的根治性放化疗——三级癌症中心不同化疗方案的回顾性分析
J Clin Transl Res. 2021 Oct 30;7(6):733-738. eCollection 2021 Dec 28.
5
Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study.1996 - 2013年英国国家癌症政策对癌症生存率趋势及社会经济不平等的影响:基于人群的研究
BMJ. 2018 Mar 14;360:k764. doi: 10.1136/bmj.k764.
6
Clinicopathological and functional implications of the inhibitor of apoptosis proteins survivin and XIAP in esophageal cancer.凋亡抑制蛋白Survivin和XIAP在食管癌中的临床病理及功能意义
Oncol Lett. 2018 Mar;15(3):3779-3789. doi: 10.3892/ol.2018.7755. Epub 2018 Jan 9.
7
Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.S-1同步放化疗作为中国老年非转移性食管鳞癌患者的替代治疗:基于系统评价和荟萃分析的证据
Oncotarget. 2017 Jun 6;8(23):37963-37973. doi: 10.18632/oncotarget.16302.
8
Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.通过抑制FAK-桩蛋白途径,Bit1基因敲低有助于抑制食管鳞状细胞癌的生长以及迁移和侵袭能力的降低。
Mol Cancer. 2016 Mar 8;15:23. doi: 10.1186/s12943-016-0507-5.
9
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients.卡铂和紫杉醇与顺铂和5-氟尿嘧啶在食管癌患者根治性放化疗中的比较。
Ann Oncol. 2014 Mar;25(3):638-643. doi: 10.1093/annonc/mdt589. Epub 2014 Feb 2.
10
Honey and cancer: sustainable inverse relationship particularly for developing nations-a review.蜂蜜与癌症:可持续的反比关系,尤其对发展中国家而言——综述。
Evid Based Complement Alternat Med. 2012;2012:410406. doi: 10.1155/2012/410406. Epub 2012 Jun 17.